BR Pharm Co., Ltd., is specilized in the PDRN

for the advancement of Regenerative Medicine and Aesthetic Medicine

BR PHARM researches for the advancement of Regenerative Medicine.


BR PHARM Co., Ltd. has developed from the API (Active Pharmaceutical Ingrediento) to the finished dosage of PDRN (Polydeoxyribonucleotide)

Based on our core technology of producing PDRN(Polydeoxyribonucleotide), BR Pharm Co., Ltd. researches a broader range of regenerative medicine technology to enable all human beings to live a beautiful and pleasant life

CEO Message


First of all, we would like to thank you for your interest in our BR Pharm's products.

We, BR Pharm Co., Ltd., step ahead to become a global leading company in Regenerative Medicine and Aesthetic Medicine through researching on PDRN(Polydeoxyribonucleotide), cell growth activator, and new protein functions. Also we play a leading role in the development of regenerative medicine products such as dermal filler, eye drops, joint injections.

We are faithfully fulfilling our social mission to contribute to a healthy society based on our corporate mission to improve quality of life through regenerative medicine.


As a solid and robust company, we are committed to principles and practice transparent management.

In accordance with BR Innovation's long-term development plan, we are making every effort to move into the global market as well as domestic.


In the future, we will continue to do our utmost to make every effort to be a leading pharmaceutical company, based on ethical management.


Thank you.

CEO Seok Soon KIM






We share knowledge and emotions through communication.  

BR PHARM Co.,Ltd. I Representative : Kim Seok Soon I Business License Neumber : 122-81-87742
Tel : +82-2-2148-6700 I Fax : +82-2-2148-6777 I E-mail
Headquarters13, Sinpyeong-ro, Sinpyeong-ri, Jijeong-myeon, Wonju-si, Gangwon-do, Republic of Korea
Research institute644 Munjeong-dong, Songpa-gu, Seoul, Korea 

Copyrigth © BR PHARM Co.,Ltd. all right reserved.